Letters Suicide risk

Bipolarity is important during treatment with antidepressants

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39121.846667.1F (Published 15 February 2007) Cite this as: BMJ 2007;334:327
  1. Daniel J Smith (smithdj3@cardiff.ac.uk),
  2. James T Walters, clinical lecturer
  1. Cardiff University, Cardiff CF14 4XN

    Rubino et al have identified that most (if not all) of the excess risk of suicide in a group of patients treated with venlafaxine could be explained by a higher burden of risk factors for suicide.1 It may be true that this group of patients had more severe or “difficult to …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe